Renalytix Statistics

Total Valuation

Renalytix has a market cap or net worth of GBP 29.81 million. The enterprise value is 28.67 million.

Market Cap	29.81M
Enterprise Value	28.67M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Renalytix has 331.21 million shares outstanding. The number of shares has increased by 39.71% in one year.

Current Share Class	n/a
Shares Outstanding	331.21M
Shares Change (YoY)	+39.71%
Shares Change (QoQ)	+62.92%
Owned by Insiders (%)	8.36%
Owned by Institutions (%)	62.01%
Float	202.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.05
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.27
EV / Sales	12.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.34

Financial Position

The company has a current ratio of 2.43

Current Ratio	2.43
Quick Ratio	2.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-232.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-128.10%
Return on Invested Capital (ROIC)	-395.18%
Return on Capital Employed (ROCE)	-340.56%
Revenue Per Employee	22,663
Profits Per Employee	-220,484
Employee Count	102
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.65% in the last 52 weeks. The beta is 1.93, so Renalytix's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	-74.65%
50-Day Moving Average	10.39
200-Day Moving Average	10.55
Relative Strength Index (RSI)	25.30
Average Volume (20 Days)	217,362

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Renalytix had revenue of GBP 2.31 million and -22.49 million in losses. Loss per share was -0.17.

Revenue	2.31M
Gross Profit	453,701
Operating Income	-18.60M
Pretax Income	-22.49M
Net Income	-22.49M
EBITDA	-18.50M
EBIT	-18.60M
Loss Per Share	-0.17

Full Income Statement

Balance Sheet

The company has 7.69 million in cash and 6.55 million in debt, giving a net cash position of 1.14 million or 0.00 per share.

Cash & Cash Equivalents	7.69M
Total Debt	6.55M
Net Cash	1.14M
Net Cash Per Share	0.00
Equity (Book Value)	-1.09M
Book Value Per Share	-0.00
Working Capital	5.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -21.45 million and capital expenditures -3,195, giving a free cash flow of -21.46 million.

Operating Cash Flow	-21.45M
Capital Expenditures	-3,195
Free Cash Flow	-21.46M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross Margin	19.63%
Operating Margin	-804.46%
Pretax Margin	-972.81%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Renalytix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.71%
Shareholder Yield	-39.71%
Earnings Yield	-75.45%
FCF Yield	-71.98%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renalytix has an Altman Z-Score of -23.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.03
Piotroski F-Score	n/a